Publication | Closed Access

VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction

Gastrointestinal OncologyMedicineApoptosisCell DeathCancer Cell BiologyHuman Gastric CancerAnti-cancer AgentDoxorubicin-induced ApoptosisPharmacologyRadiation OncologyNovel Synthetic DerivativeCancer ResearchOxidative Stress